Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9366536rdf:typepubmed:Citationlld:pubmed
pubmed-article:9366536lifeskim:mentionsumls-concept:C0006141lld:lifeskim
pubmed-article:9366536lifeskim:mentionsumls-concept:C1318309lld:lifeskim
pubmed-article:9366536lifeskim:mentionsumls-concept:C0220908lld:lifeskim
pubmed-article:9366536lifeskim:mentionsumls-concept:C1417725lld:lifeskim
pubmed-article:9366536lifeskim:mentionsumls-concept:C0439148lld:lifeskim
pubmed-article:9366536lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:9366536pubmed:issue10lld:pubmed
pubmed-article:9366536pubmed:dateCreated1997-11-25lld:pubmed
pubmed-article:9366536pubmed:abstractTextWe recently changed from using fine needle aspiration cytology to using core biopsy exclusively in the assessment of screen detected abnormalities. Two hundred and two biopsies (1% of women screened) were performed. Surgical histological confirmation was obtained in 111 patients (101 malignant and 10 benign). The remaining patients were either returned to standard 3-yearly screening or early repeat screening after 1 year. Analysis of the results was performed in accordance with the standards specified in the National Health Service Breast Screening Programme (NHSBSP) Publication Number 22. Absolute sensitivity was 89.3%, complete sensitivity was 93.2%, specificity (including patients undergoing both surgical excision and follow-up) was 88.7%. The predictive value of a positive (malignant) core biopsy result was 100%. The false negative rate was 3.9%. Twelve (5.9%) biopsies were classified inadequate for diagnosis. Core biopsy is a safe and accurate way of assessing screen detected abnormalities and can be used as a substitute for fine needle aspiration cytology with results that exceed the National Health Service Breast Screening Programme target standards, even in the learning phase.lld:pubmed
pubmed-article:9366536pubmed:languageenglld:pubmed
pubmed-article:9366536pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9366536pubmed:citationSubsetIMlld:pubmed
pubmed-article:9366536pubmed:statusMEDLINElld:pubmed
pubmed-article:9366536pubmed:monthOctlld:pubmed
pubmed-article:9366536pubmed:issn0009-9260lld:pubmed
pubmed-article:9366536pubmed:authorpubmed-author:WightD GDGlld:pubmed
pubmed-article:9366536pubmed:authorpubmed-author:WarrenRRlld:pubmed
pubmed-article:9366536pubmed:authorpubmed-author:GoddardM JMJlld:pubmed
pubmed-article:9366536pubmed:authorpubmed-author:FlowerC DCDlld:pubmed
pubmed-article:9366536pubmed:authorpubmed-author:FreemanA HAHlld:pubmed
pubmed-article:9366536pubmed:authorpubmed-author:BobrowLLlld:pubmed
pubmed-article:9366536pubmed:authorpubmed-author:BrittonP DPDlld:pubmed
pubmed-article:9366536pubmed:authorpubmed-author:SinnatambyRRlld:pubmed
pubmed-article:9366536pubmed:issnTypePrintlld:pubmed
pubmed-article:9366536pubmed:volume52lld:pubmed
pubmed-article:9366536pubmed:ownerNLMlld:pubmed
pubmed-article:9366536pubmed:authorsCompleteYlld:pubmed
pubmed-article:9366536pubmed:pagination764-7lld:pubmed
pubmed-article:9366536pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:meshHeadingpubmed-meshheading:9366536-...lld:pubmed
pubmed-article:9366536pubmed:year1997lld:pubmed
pubmed-article:9366536pubmed:articleTitleChanging to core biopsy in an NHS breast screening unit.lld:pubmed
pubmed-article:9366536pubmed:affiliationDepartment of Radiology, Addenbrooke's Hospital and Cambridge University, UK.lld:pubmed
pubmed-article:9366536pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9366536pubmed:publicationTypeClinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9366536lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9366536lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9366536lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9366536lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9366536lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9366536lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9366536lld:pubmed